Title | Author(s) | Issue date | ???itemlist.??? |
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms | Hatzimichael, E.; Dasoula, A.; Benetatos, L.; Makis, A.; Stebbing, J.; Crook, T.; Syrrou, M.; Bourantas, K. L. | 24-Nov-2015 | - |
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia | Hatzimichael, E.; Benetatos, L.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Georgiou, I.; Syrrou, M.; Stebbing, J.; Coley, H. M.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |
Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications | Hatzimichael, E.; Dasoula, A.; Kounnis, V.; Benetatos, L.; Nigro, C. L.; Lattanzio, L.; Papoudou-Bai, A.; Dranitsaris, G.; Briasoulis, E.; Crook, T. | 24-Nov-2015 | - |
Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis | Benetatos, L.; Chaidos, A.; Alymara, V.; Vassou, A.; Bourantas, K. L. | 24-Nov-2015 | - |
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes | Benetatos, L.; Hatzimichael, E.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Syrrou, M.; Georgiou, I.; Bourantas, K. L. | 24-Nov-2015 | - |
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient | Benetatos, L.; Hatzimichael, E.; Vassou, A.; Bourantas, K. L. | 24-Nov-2015 | - |
Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura | Benetatos, L.; Vassou, A.; Bourantas, K. L. | 24-Nov-2015 | - |
Malignancies in beta-thalassemia patients: a single-center experience and a concise review of the literature | Benetatos, L.; Alymara, V.; Vassou, A.; Bourantas, K. L. | 24-Nov-2015 | - |
Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromes | Benetatos, L.; Dasoula, A.; Syed, N.; Hatzimichael, E.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |
Non-secretory multiple myeloma with involvement of the hand as initial manifestation | Benetatos, L.; Alymara, V.; Chaidos, A.; Vassou, A.; Bourantas, K. L. | 24-Nov-2015 | - |
Peripheral blood flow cytometry based diagnosis in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: implications for more extensive use | Benetatos, L.; Dova, L.; Baxevanos, G.; Kolaitis, N. I.; Bourantas, K. L.; Vartholomatos, G. | 24-Nov-2015 | - |
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions | Benetatos, L.; Dasoula, A.; Hatzimichael, E.; Syed, N.; Voukelatou, M.; Dranitsaris, G.; Bourantas, K. L.; Crook, T. | 24-Nov-2015 | - |
Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma | Benetatos, L.; Dasoula, A.; Hatzimichael, E.; Georgiou, I.; Syrrou, M.; Bourantas, K. L. | 24-Nov-2015 | - |
Rituximab as first line treatment for MALT lymphoma of extraocular muscles | Benetatos, L.; Alymara, V.; Asproudis, I.; Bourantas, K. L. | 24-Nov-2015 | - |
Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support | Hatzimichael, E.; Benetatos, L.; Stebbing, J.; Kapsali, E.; Panayiotopoulou, S.; Bourantas, K. L. | 24-Nov-2015 | - |
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease | Hatzimichael, E.; Dranitsaris, G.; Dasoula, A.; Benetatos, L.; Stebbing, J.; Crook, T.; Bourantas, K. L. | 24-Nov-2015 | - |